Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)
This study is not yet open for participant recruitment.
Verified July 2011 by Samsung Medical Center
Study NCT01404637   Information provided by Samsung Medical Center

First Received on July 26, 2011.   Last Updated on July 30, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Benign Prostatic Hyperplasia
Additional conditions recognized in this trial
Hyperplasia
Prostatic Hyperplasia
More general conditions related to this trial
Genital Diseases, Male
Pathologic Processes
Prostatic Diseases
Interventions listed in this trial
Tamsulosin 0.4mg
Tamsulosin 0.2mg
Additional drug interventions recognized in this trial
Tamsulosin
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Samsung Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services